Anzeige
Mehr »
Mittwoch, 12.11.2025 - Börsentäglich über 12.000 News
BREAKING NEWS: Bohrprogramm gestartet - historisches Uranpotenzial wird jetzt "aufgebohrt"
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 882803 | ISIN: DK0010253921 | Ticker-Symbol: 5RF
Frankfurt
12.11.25 | 09:28
81,20 Euro
+2,27 % +1,80
1-Jahres-Chart
SCHOUW & CO A/S Chart 1 Jahr
5-Tage-Chart
SCHOUW & CO A/S 5-Tage-Chart
RealtimeGeldBriefZeit
80,9081,6012:16
GlobeNewswire (Europe)
40 Leser
Artikel bewerten:
(0)

Aktieselskabet Schouw & Co.: Interim report - third quarter of 2025

Interim report - third quarter of 2025

Wednesday, Schouw & Co. released its interim report for the third quarter of 2025; Schouw & Co. delivered an overall strong Q3 2025 performance in an environment marked by shifting uncertainties.

Highlights

  • DKK 9.2bn revenue - a 4% decrease
  • DKK 878m EBITDA - a 5% improvement
  • DKK 894m cash flow from operations - a 23% decrease
  • DKK 15.53 earnings per share - a 6% improvement
  • 12.8% ROIC excluding goodwill - a 0.4 pp decrease
  • Full-year revenue and EBITDA guidance narrowed towards the lower end of the previous ranges.

Statement by Jens Bjerg Sørensen, President of Schouw & Co.

- The shifting uncertainties continued in the third quarter of 2025, but once again the conglomerate's strength and diversified exposure proved its value. Market headwinds in the quarter in BioMar's important Norwegian market is offset by continued strong progress in HydraSpecma and Fibertex Personal Care, and the consolidated profit in the quarter was in line with expectations. Investments remain at a controlled level and cash flow generation is attractive.

In Schouw & Co., we have used the current uncertain environment to prepare for a future characterised by volatility and challenges to global trade. We are optimising our global footprint and securing a long-term competitive cost base. This involves restructuring costs of almost DKK 100 million in 2025 but will significantly strengthen our position and platform.

We continue investigating whether a potential separate listing of BioMar would create value for the shareholders of Schouw & Co. and the process is progressing as expected. A value-creating IPO of BioMar is a natural consequence of our strategic approach to best-ownership and future-proofing and would leave Schouw & Co. in a strong position with an even healthier balance sheet. We expect to continue investing in our portfolio businesses and are also positive about the potential of expanding the portfolio with a new platform investment.

Video conference call (in English) in relation to the interim report

  • Wednesday, 12 November 2025 at 10:00 CET

Please attend via this link: www.schouw.com/cc

Aktieselskabet Schouw & Co.

Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, tel. +45 8611 22 22


© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.